The use of antimicrobial agents in patients with hepatic and renal dysfunction.
D000617:Aminoglycosides / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000378:metabolism / Q000627:therapeutic use*; D002511:Cephalosporins / Q000627:therapeutic use; D002701:Chloramphenicol / Q000627:therapeutic use; D004334:Drug Administration Schedule; D006801:Humans; D007239:Infections / Q000150:complications* / Q000188:drug therapy; D007674:Kidney Diseases / Q000150:complications* / Q000503:physiopathology; D008107:Liver Diseases / Q000150:complications* / Q000503:physiopathology; D010406:Penicillins / Q000627:therapeutic use; D010530:Peritoneal Dialysis; D006435:Renal Dialysis
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D002511:Cephalosporins; D010406:Penicillins; D002701:Chloramphenicol